Intrinsic Value of S&P & Nasdaq Contact Us

Shattuck Labs, Inc. STTK NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.50
+54.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Shattuck Labs, Inc. (STTK) has a negative trailing P/E of -15.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -6.49%.

Criteria proven by this page:

  • VALUE (74/100, Pass) — analyst target implies upside (+54.9%).
  • Trailing Earnings Yield -6.49% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $10.50 (+54.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 55/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
55/100
SG Score
View full scorecard →
VALUE
74/100
Price-to-Earnings & upside
Proven by this page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
15/100
→ Income
GROWTH
100/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — STTK

Valuation Multiples
P/E (TTM)-15.4
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio9.13
P/S Ratio347.25
EV/EBITDA-6.3
Per Share Data
EPS (TTM)$-0.47
Book Value / Share$0.79
Revenue / Share$0.01
FCF / Share$-0.38
Yields & Fair Value
Earnings Yield-6.49%
Dividend Yield0.00%
Analyst Target$10.50 (+54.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -39.4 0.00 -26.27 12.97 -
2019 -33.7 -2.06 -23.38 81.70 -
2020 -59.8 -1.10 7.06 220.36 -
2021 -8.0 -0.37 1.32 11.92 -
2022 -1.0 -0.01 0.55 149.50 -
2023 -3.5 0.23 2.10 183.31 -
2024 -0.8 0.03 0.77 10.74 -
2025 -5.2 0.10 3.08 253.99 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-0.49 $22.44M $-7.39M -32.9%
2019 $-0.57 $9.89M $-23.88M -241.6%
2020 $-0.85 $9.93M $-35.44M -356.7%
2021 $-1.06 $30.02M $-44.35M -147.7%
2022 $-2.37 $652K $-101.95M -15635.7%
2023 $-2.05 $1.66M $-87.3M -5268.4%
2024 $-1.49 $5.72M $-75.41M -1318.1%
2025 $-0.70 $1M $-48.81M -4880.9%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.52 $-0.85 – $-0.39 $1.6M $1.6M – $1.6M 5
2027 $-0.48 $-0.86 – $-0.31 $19.3M $19.3M – $19.3M 5
2028 $-0.55 $-1.02 – $-0.32 $2.5M $2.5M – $2.5M 5
2029 $-0.59 $-0.59 – $-0.59 $1.21M $1.21M – $1.21M 1
2030 $-0.89 $-0.89 – $-0.89 $1.27M $1.27M – $1.27M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message